title: Clopidogrel and endothelial injury after percutaneous coronary interventions: beyond the antiplatelet effects.
authors.forename: Goran
authors.initials: G
authors.lastname: Rudez
authors.forename: Hendricus J
authors.initials: HJ
authors.lastname: Duckers
authors.forename: Maarten L
authors.initials: ML
authors.lastname: Simoons
mesh_terms: D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects*; D001792:Blood Platelets / Q000187:drug effects; D000077144:Clopidogrel; D004730:Endothelium, Vascular / Q000187:drug effects* / Q000293:injuries; D006801:Humans; D017202:Myocardial Ischemia / Q000628:therapy*; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage*; D019919:Prosthesis Implantation / Q000009:adverse effects; D058919:Purinergic P2 Receptor Antagonists; D058925:Receptors, Purinergic P2Y12; D015607:Stents / Q000009:adverse effects; D013988:Ticlopidine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D014652:Vascular Diseases / Q000175:diagnosis* / Q000209:etiology / Q000517:prevention & control
chemical_list: C548576:P2RY12 protein, human; D010975:Platelet Aggregation Inhibitors; D058919:Purinergic P2 Receptor Antagonists; D058925:Receptors, Purinergic P2Y12; D000077144:Clopidogrel; D013988:Ticlopidine